Bruton tyrosine kinase inhibition: Clinical relevance beyond B cells

被引：10
|
作者：
Banoth, Balaji [1 ]
Cassel, Suzanne L. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Dept Med, Womens Guild Lung Inst, Los Angeles, CA 90048 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 140卷 / 04期
基金：
美国国家卫生研究院;
关键词：
Nucleotide-binding leucine-rich repeat receptor family pyrin domain containing protein 3; Bruton tyrosine kinase; ibrutinib;
D O I：
10.1016/j.jaci.2017.03.041
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：985 / 987
页数：3
相关论文
共 50 条
  • [31] Bruton Tyrosine Kinase Degraders in B-Cell Malignancies
    Huynh, Tiana
    Rodriguez-Rodriguez, Sonia
    Danilov, Alexey V.
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (05) : 619 - 626
  • [32] Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
    Roschewski, Mark
    Lionakis, Michail S.
    Sharman, Jeff P.
    Roswarski, Joseph
    Goy, Andre
    Monticelli, M. Andrew
    Roshon, Michael
    Wrzesinski, Stephen H.
    Desai, Jigar V.
    Zarakas, Marissa A.
    Collen, Jacob
    Rose, Keith M.
    Hamdy, Ahmed
    Izumi, Raquel
    Wright, George W.
    Chung, Kevin K.
    Baselga, Jose
    Staudt, Louis M.
    Wilson, Wyndham H.
    SCIENCE IMMUNOLOGY, 2020, 5 (48)
  • [33] Susceptibility to Cryptococcus neoformans Infection with Bruton's Tyrosine Kinase Inhibition
    Messina, Julia A.
    Giamberardino, Charles D.
    Tenor, Jennifer L.
    Toffaletti, Dena L.
    Schell, Wiley A.
    Asfaw, Yohannes G.
    Palmucci, Julia R.
    Lionakis, Michail S.
    Perfect, John R.
    INFECTION AND IMMUNITY, 2023, 91 (08)
  • [34] Bruton's tyrosine kinase inhibition suppresses pathological retinal angiogenesis
    Chen, Siyue
    Wang, Xiaohong
    Liu, Qiang
    Yan, Hua
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [35] Unveiling the reaction mechanism of bruton's tyrosine kinase inhibition by ibrutinib
    Barragan, Angela M.
    Roux, Benoit
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 8 - 8
  • [36] B cell-mediated experimental CNS autoimmunity is modulated by inhibition of Bruton's tyrosine kinase
    Torke, S.
    Grenningloh, R.
    Boschert, U.
    Weber, M. S.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 42 - 43
  • [37] Targeting Bruton's tyrosine kinase in B cell malignancies
    Hendriks, Rudi W.
    Yuvaraj, Saravanan
    Kil, Laurens P.
    NATURE REVIEWS CANCER, 2014, 14 (04) : 219 - 232
  • [38] Bruton’s Tyrosine Kinase (BTK) Inhibitors in Clinical Trials
    Jan A. Burger
    Current Hematologic Malignancy Reports, 2014, 9 : 44 - 49
  • [39] Bruton Tyrosine Kinase Inhibition and Its Role as an Emerging Treatment in Pemphigus
    Patsatsi, Aikaterini
    Murrell, Dedee F. F.
    FRONTIERS IN MEDICINE, 2021, 8
  • [40] Bruton's Tyrosine Kinase Inhibition Is Associated with Manageable Cardiac Toxicity
    Romisher, Alison
    Carver, Joseph
    Schuster, Stephen J.
    Svoboda, Jakub
    Vandegrift, Alexandra
    Rago, Allison
    O'Quinn, Rupal
    Ky, Bonnie
    Mato, Anthony R.
    BLOOD, 2015, 126 (23)
12345